New York State Common Retirement Fund’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
93,808
+22,358
| +31% | +$293K | ﹤0.01% | 1594 |
|
|
2025
Q1 | $1.57M | Buy |
71,450
+84
| +0.1% | +$1.85K | ﹤0.01% | 1469 |
|
|
2024
Q4 | $1.91M | Buy |
71,366
+4,284
| +6% | +$114K | ﹤0.01% | 1439 |
|
|
2024
Q3 | $1.79M | Buy |
67,082
+37,236
| +125% | +$994K | ﹤0.01% | 1446 |
|
|
2024
Q2 | $538K | Sell |
29,846
-38,852
| -57% | -$700K | ﹤0.01% | 2019 |
|
|
2024
Q1 | $1.25M | Sell |
68,698
-1,995
| -3% | -$36.4K | ﹤0.01% | 1675 |
|
|
2023
Q4 | $773K | Buy |
70,693
+26,822
| +61% | +$293K | ﹤0.01% | 1908 |
|
|
2023
Q3 | $251K | Buy |
43,871
+30,522
| +229% | +$175K | ﹤0.01% | 2323 |
|
|
2023
Q2 | $103K | Sell |
13,349
-35
| -0.3% | -$270 | ﹤0.01% | 2799 |
|
|
2023
Q1 | $89K | Sell |
13,384
-10,731
| -44% | -$71.4K | ﹤0.01% | 2842 |
|
|
2022
Q4 | $216K | Buy |
24,115
+8,090
| +50% | +$72.5K | ﹤0.01% | 2692 |
|
|
2022
Q3 | $158K | Hold |
16,025
| – | – | ﹤0.01% | 2852 |
|
|
2022
Q2 | $128K | Sell |
16,025
-12,149
| -43% | -$97K | ﹤0.01% | 2983 |
|
|
2022
Q1 | $273K | Buy |
28,174
+9,714
| +53% | +$94.1K | ﹤0.01% | 2687 |
|
|
2021
Q4 | $282K | Buy |
18,460
+7,735
| +72% | +$118K | ﹤0.01% | 2735 |
|
|
2021
Q3 | $178K | Buy |
10,725
+125
| +1% | +$2.08K | ﹤0.01% | 2949 |
|
|
2021
Q2 | $226K | Buy |
+10,600
| New | +$226K | ﹤0.01% | 2996 |
|